Vimarsana
Biggest News Aggregation in the World

Page 47 - Accessed August News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed August. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed August Today - Breaking & Trending Today

Events DC Implements Synexis BioDefense System to Improve Indoor Air Quality at Walter E. Washington Convention Center - Vimarsana News

Events DC Implements Synexis BioDefense System to Improve Indoor Air Quality at Walter E. Washington Convention Center

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Source: apnews.com
FDA Authorizes Use of COVID-19 Antibody Therapy for Postexposure Prophylaxis - Vimarsana News

FDA Authorizes Use of COVID-19 Antibody Therapy for Postexposure Prophylaxis

The FDA has authorized the use of REGEN-COV (casirivimab and imdevimab) for post-exposure prophylaxis of COVID-19.

FDA Authorizes Use of COVID-19 Antibody Therapy for Postexposure Prophylaxis - Vimarsana News

FDA Authorizes Use of COVID-19 Antibody Therapy for Postexposure Prophylaxis

Credit: Regeneron. The Food and Drug Administration (FDA) has authorized the use of REGEN-COV (casirivimab and imdevimab) for postexposure prophylaxis of COVID-19 in individuals (12 years of age and older weighing at least 40kg) who are at high risk for progression to severe COVID-19, including hospitalization or death. The investigational agent was previously granted Emergency Use Authorization (EUA) for the treatment of mild to moderate COVID-19. REGEN-COV consists of 2 potent, virus-neutralizing antibodies that bind noncompetitively to the receptor binding domain of the SARS...

Source: empr.com
Global Blood Therapeutics, Inc.: New Data Supporting the Potential Use of Oxbryta (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual Congress - Vimarsana News

Global Blood Therapeutics, Inc.: New Data Supporting the Potential Use of Oxbryta (voxelotor) in Children Ages 4 to 11 Years with Sickle Cell Disease Presented at European Hematology Association 2021 Virtual Congress

Analysis from Phase 2a HOPE-KIDS 1 Study Featured in Oral Presentation Two Real-world Data Studies Demonstrated Sustained Improvements in Hemoglobin with Oxbryta Consistent with Results from the Phase

How important is soil quality to addressing climate change? It's critical, and here's a blueprint for refocusing American R&D - Vimarsana News

How important is soil quality to addressing climate change? It's critical, and here's a blueprint for refocusing American R&D

COVID-19 and the resulting economic crisis have highlighted and exacerbated the plight of American farmers, while also threatening already